Averion International Corp. Names Christopher Codeanne Chief Financial Officer

BOSTON--(BUSINESS WIRE)--Averion International Corp. (OTCBB:AVRO), a clinical research organization (CRO) specializing in oncology, dermatology, nephrology and medical devices, today announced the appointment of Christopher G. Codeanne, CPA, as chief financial officer.

MORE ON THIS TOPIC